Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.

This publication has 72 references indexed in Scilit:

• Hormonal regulation of extracellular plasminogen activators and Mr ∼ 54000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies
  Molecular and Cellular Endocrinology, 1986
• Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass
  FEBS Letters, 1986
• Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies
  British Journal of Dermatology, 1985
• Proenzyme to urokinase‐type plasminogen activator in the mouse in vivo
  FEBS Letters, 1985
• Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma.
  The Journal of cell biology, 1984
• Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
  The Journal of cell biology, 1983
• Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells
  Biochemical and Biophysical Research Communications, 1983
• HUMAN FIBROBLASTS PRODUCE INHIBITOR DIRECTED AGAINST PLASMINOGEN ACTIVATOR WHEN TREATED WITH GLUCOCORTICOIDS*
  Annals of the New York Academy of Sciences, 1981
• Concomitant secretion by transformed SVWI38-VA13-2RA cells of plasminogen activator(s) and substance(s) which prevent their detection
  Biochemical and Biophysical Research Communications, 1978
• Protein a from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins
  FEBS Letters, 1972